These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Therapeutic role of mitoxantrone in multiple sclerosis. Neuhaus O; Kieseier BC; Hartung HP Pharmacol Ther; 2006 Jan; 109(1-2):198-209. PubMed ID: 16095713 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy and multiple sclerosis: The devil is in the details. Bourdette D; Whitham R Neurology; 2010 May; 74(18):1410-1. PubMed ID: 20439842 [No Abstract] [Full Text] [Related]
6. Leukaemia due to mitoxantrone. Prescrire Int; 2007 Aug; 16(90):153-6. PubMed ID: 17724842 [TBL] [Abstract][Full Text] [Related]
8. [Mitoxantrone for the treatment of patients with multiple sclerosis]. Komori M; Kondo T; Tanaka M Brain Nerve; 2009 May; 61(5):575-80. PubMed ID: 19514518 [TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone-induced extravasation. Luke E Oncol Nurs Forum; 2005 Jan; 32(1):27-9. PubMed ID: 15682531 [No Abstract] [Full Text] [Related]
10. [Immunosuppressants and multiple sclerosis]. Ruiz-Peña JL; Izquierdo-Ayuso G Rev Neurol; 2002 Aug 16-31; 35(4):373-80. PubMed ID: 12235571 [TBL] [Abstract][Full Text] [Related]
11. [Mitoxantrone, a new reality]. Ruiz-Peña JL; Izquierdo G Rev Neurol; 2003 Apr 1-15; 36(7):698-9. PubMed ID: 12666055 [No Abstract] [Full Text] [Related]
12. Mitoxantrone for multiple sclerosis in clinical practice. Rizvi SA; Zwibel H; Fox EJ Neurology; 2004 Dec; 63(12 Suppl 6):S25-7. PubMed ID: 15623666 [TBL] [Abstract][Full Text] [Related]
13. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis. Sumrall A; Dreiling B J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254 [TBL] [Abstract][Full Text] [Related]
14. [Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis]. Feuillet L; Guedj E; Eusebio A; Malikova I; Pelletier J; Mundler O; Ali Chérif A; Rev Neurol (Paris); 2003 Dec; 159(12):1169-72. PubMed ID: 14978418 [TBL] [Abstract][Full Text] [Related]
15. [Mitoxanthrone in the therapy of multiple sclerosis]. Kieseier BC; Gold R; Hartung HP Nervenarzt; 2003 Oct; 74(10):906-10. PubMed ID: 14551698 [TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone immunotherapy in multiple sclerosis. Gonsette RE Mult Scler; 1996 Jul; 1(6):329-32. PubMed ID: 9345411 [TBL] [Abstract][Full Text] [Related]
17. The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Goodin DS; Arnason BG; Coyle PK; Frohman EM; Paty DW; Neurology; 2003 Nov; 61(10):1332-8. PubMed ID: 14638950 [TBL] [Abstract][Full Text] [Related]
18. Mitoxantrone for multiple sclerosis causing acute lymphoblastic leukemia. Cartwright MS; Jeffery DR; Lewis ZT; Koty PP; Stewart WT; Molnár I Neurology; 2007 May; 68(19):1630-1. PubMed ID: 17485652 [No Abstract] [Full Text] [Related]
19. Invited commentary. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting. Pandit L Neurol India; 2009; 57(4):424-5. PubMed ID: 19827224 [No Abstract] [Full Text] [Related]
20. Invited commentary. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting. Brandes DW Neurol India; 2009; 57(4):423-4. PubMed ID: 19827223 [No Abstract] [Full Text] [Related] [Next] [New Search]